157 / 490
155
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
TUESDAY 3 MAY 2016
will be given. Safety issues will be covered, and major clinical trial successes and challenges will be
highlighted. In addition, future opportunities for advances in preclinical and clinical development of
combination therapies will be presented.
Chair: H. Lyng (Norway)
Co-chair: L. Livi (Italy)
11:00 > Interaction of radiotherapy with molecular targeting agents
Speaker: P. Harari (USA)
SP-0603
11:20 > Challenges combining radiotherapy with immunotherapy
Speaker: S. Formenti (USA)
SP-0604
11:40 > New strategies to targeting tumour angiogenesis and hypoxia
Speaker: O. Chinot (France)
SP-0605
Symposium with Proffered Papers
RADIOMICS - THE FUTURE OF RADIOTHERAPY?
11:00 - 12:00 | ISTANBUL
Chair: P. Lambin (The Netherlands)
Co-chair: G. Mantini (Italy)
11:00 > Imaging-genomics: identifying molecular phenotypes by integrating
radiomics and genomics data
Speaker: TBC
SP-0606
11:15 > PET/CT heterogeneity quantification through texture analysis: potential
role for prognostic and predictive models
Speaker: M. Hatt (France)
SP-0607
11:30 > The potential of radiomics for radiotherapy individualisation
Speaker: E. Troost (Germany), K. Pilz, S. Löck, S. Leger, C. Richter
SP-0608
11:45 > Radiomic CT features for evaluation of EGFR and KRAS mutation status
in patients with advanced NSCLC
E.E.C. De Jong (The Netherlands), W. Van Elmpt, L.E.L. Hendriks,
R.T.H. Leijenaar, A.M.C. Dingemans, P. Lambin
OC-0609
Symposium
RADIOBIOLOGY OF PROTON / CARBON / HEAVY IONS
11:00 - 12:00 | LONDRA
Chair: M. Pruschy (Switzerland)
Co-chair: M. Amichetti (Italy)